Multidisciplinary meeting on urological cancers aims to benefit cancer patients

(European Association of Urology) Urological cancer patients will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is necessary to take cancer-related research and medical practice to the next level. The 2nd European Multidisciplinary Meeting on Urological Cancers Embracing Excellence in Prostate, Bladder and Kidney Cancer which is to take place on Nov. 27-29, 2009, in Barcelona, brings together urologists, radiologists and medical oncologists by enabling them to share their knowledge and experience.

source : www.eurekalert.org

Related News:

• Kidney Cancer Drug Shows Promising Results
• Launch Of Ipsen’s Decapeptyl(R) 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Prostate Cancer
• Barker Hypothesis Strengthened By Ancient Tooth Remains
• Scientists At Rice University Discover That ‘Nanobubbles’ Kill Cancer
• AM: Opioid Gains Long-Term Control of Neuropathic Cancer Pain (CME/CE)
• Launch Of Ipsen’s Decapeptyl 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Advanced Or Metastatic Hormone-Dependent Prostate Cancer
• Green Tea Extracts Halt Growth of Prostate Cancer Tumors
• AM: Opioid Shows Long-Term Control of Neuropathic Cancer Pain (CME/CE)
• Recordati : Silodosin Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia
• EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractory Prostate Cancer

Details :
Submited at Thursday, November 19th, 2009 at 1:01 pm on Cancer and Oncology by robert
Comment RSS 2.0 - leave a comment - trackback